Chronic Kidney Disease (CKD) Drugs Market is projected to reach USD 23.8 Billion, garnering a 4.2% CAGR from 2024 to 2034: Transparency Market Research, Inc.
24. September 2024 08:32 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Transparency Market Research Inc. -, Sept. 24, 2024 (GLOBE NEWSWIRE) -- The global chronic kidney disease (CKD) drugs market (만성신장질환(CKD) 치료제 시장) was projected...
RAS-acting Agents Market Size to Reach USD 13.4 Bn by 2031 with CAGR of 4.2% | TMR Study
11. April 2023 15:00 ET
|
Transparency Market Research
Wilmington, Delaware, United States, April 12, 2023 (GLOBE NEWSWIRE) -- The RAS-acting agents market was valued at USD 9.7 Bn in 2022 and the industry is expected to reach USD 13.4 Bn by 2031. The...
Anti-Viral Therapies Market Growth ($82.92 Billion by 2028) Driven by Branded Drugs Segment during (2022-2028) – Global Report by The Insight Partners
09. März 2023 08:46 ET
|
The Insight Partners
New York, March 09, 2023 (GLOBE NEWSWIRE) -- According to The Insight Partners, “Anti-Viral Therapies Market Size, Share, Growth, Trends and Global Forecast to 2028 - COVID-19 Impact and Global...
Global Chronic Kidney Disease Drugs Market to Surpass US$ 17,832.5 Million by 2030, Says Coherent Market Insights (CMI)
19. Oktober 2022 09:15 ET
|
CMI
Seattle, Oct. 19, 2022 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global chronic kidney disease drugs market is estimated to be valued at US$ 13,220.0 million in 2022 and is...
Global Hemoglobinopathies Market is Expected to Reach $7.0 Billion by 2031: Says AMR
25. August 2022 08:33 ET
|
Allied Market Research
Portland, OR, Aug. 25, 2022 (GLOBE NEWSWIRE) -- The Global Hemoglobinopathies Market size was estimated at $4.2 billion in 2021 and is expected to hit $7.0 billion by 2031, registering a CAGR of...
Global Liver Fibrosis Treatment Market to Surpass US$ 33.4 Billion by 2030, Says Coherent Market Insights (CMI)
08. August 2022 09:10 ET
|
CMI
Seattle, Aug. 08, 2022 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global liver fibrosis treatment market is estimated to be valued at US$ 14.7 billion in 2022 and is expected to...
The Heart Failure Society of America Launches New App to Help People Living With Heart Failure, in Partnership With Self Care Catalysts
02. Februar 2016 08:30 ET
|
Self Care Catalysts;Heart Failure Society of America
BETHESDA, MD--(Marketwired - February 02, 2016) - The Heart Failure Society of America, Inc. (HFSA) kicked off 2016 with the launch of a new app, Heart Failure Health Storylines, to support...